Neutralizing GDF8 epitope-based growth enhancing vaccine

Details Neutralizing GDF8 epitope-based growth enhancing vaccine Neutralizing GDF8 epitope-based growth enhancing vaccine

2008-05-13

2008-05-13

Kemmerer, Elizabeth C. (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S008100, C514S013800, C424S130100, C424S139100, C424S141100, C424S142100, C530S300000, C530S324000, C530S326000

Reexamination Certificate

active

07371726

ABSTRACT:
The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.

REFERENCES:
patent: 5422110 (1995-06-01), Potter et al.
patent: 5476657 (1995-12-01), Potter et al.
patent: 5708155 (1998-01-01), Potter et al.
patent: 5827733 (1998-10-01), Lee et al.
patent: 5871750 (1999-02-01), Potter
patent: 5977438 (1999-11-01), Turpen et al.
patent: 6004937 (1999-12-01), Wood et al.
patent: 6042832 (2000-03-01), Koprowski et al.
patent: 6096506 (2000-08-01), Lee et al.
patent: 6368597 (2002-04-01), Strassmann et al.
patent: 6369201 (2002-04-01), Barker et al.
patent: 6399312 (2002-06-01), Wu-Wong et al.
patent: 6468535 (2002-10-01), Lee et al.
patent: 6607884 (2003-08-01), Lee et al.
patent: 6617440 (2003-09-01), Findly
patent: 6656475 (2003-12-01), Lee et al.
patent: 6730306 (2004-05-01), Pogue et al.
patent: 7037501 (2006-05-01), El Halawani et al.
patent: 7056512 (2006-06-01), Klysner et al.
patent: 7070784 (2006-07-01), Halkier et al.
patent: 2001/0014330 (2001-08-01), Harland et al.
patent: 2002/0127234 (2002-09-01), El Halawanl et al.
patent: 2002/0157125 (2002-10-01), Lee et al.
patent: 2003/0065137 (2003-04-01), Barker et al.
patent: 2003/0074680 (2003-04-01), Lee et al.
patent: 2006/0159696 (2006-07-01), Junker et al.
patent: 2006/0281075 (2006-12-01), Smith et al.
patent: 0 690 873 (2003-06-01), None
patent: 2 333 706 (1999-04-01), None
patent: WO 98/33887 (1999-08-01), None
patent: WO 99/42573 (1999-08-01), None
patent: WO 01/26672 (2001-04-01), None
patent: WO 03/027248 (2003-04-01), None
patent: WO 2004/052930 (2004-06-01), None
patent: WO 2004/058988 (2004-07-01), None
Gonzalez-Cadavid, Nestor F., et al., “Organization of the human myostatin gene . . . ,” Proc. Natl. Acad. Sci. USA 95:14938-14943 (Dec. 1998).
McPherron, Alexandra C., et al., “Regulation of skeletal muscle . . . ,” Nature 387:83-90 (May 1997).
Rebbapragada, A., et al., “Myostatin signals through a . . . ,” Molecular and Cellular Biology 23(20):7230-7242 (Oct. 2003).
R&D Sytems, Inc., Antibody Reference Guide and Catalog, May 1, 2003.
PCT International Search Report dated May 25, 2005 for corresponding PCT Application No. PCT/US2004/043125.
Geysen H M et al.; “Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single aminoacid”. Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington DC; vol. 81 (1) Jul. 1984: 3998-4002.
PCT International Search Report mail date Sep. 20, 2006 for corresponding PCT application No. PCT/US2005/046363, international filing date Dec. 21, 2005.

Affiliated with

Also associated with

Rating

Neutralizing GDF8 epitope-based growth enhancing vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neutralizing GDF8 epitope-based growth enhancing vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing GDF8 epitope-based growth enhancing vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2780500